Appropriate calibration curve fitting in ligand binding assays

Calibration curves for ligand binding assays are generally characterized by a nonlinear relationship between the mean response and the analyte concentration. Typically, the response exhibits a sigmoidal relationship with concentration. The currently accepted reference model for these calibration curves is the 4-parameter logistic (4-PL) model, which optimizes accuracy and precision over the maximum usable calibration range. Incorporation of weighting into the model requires additional effort but generally results in improved calibration curve performance. For calibration curves with some asymmetry, introduction of a fifth parameter (5-PL) may further improve the goodness of fit of the experimental data to the algorithm. Alternative models should be used with caution and with knowledge of the accuracy and precision performance of the model across the entire calibration range, but particularly at upper and lower analyte concentration areas, where the 4-and 5-PL algorithms generally outperform alternative models. Several assay design parameters, such as placement of calibrator concentrations across the selected range and assay layout on multiwell plates, should be considered, to enable optimal application of the 4- or 5-PL model. The fit of the experimental data to the model should be evaluated by assessment of agreement of nominal and model-predicted data for calibrators.

[1]  Karpinski Kf,et al.  Optimality assessment in the enzyme-linked immunosorbent assay (ELISA). , 1990 .

[2]  W C Smith,et al.  Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications. , 1998, Journal of biopharmaceutical statistics.

[3]  David M. Rocke,et al.  Optimal design for ELISA and other forms of immunoassay , 1997 .

[4]  K F Karpinski,et al.  Optimality assessment in the enzyme-linked immunosorbent assay (ELISA). , 1990, Biometrics.

[5]  Krys J. Miller,et al.  Workshop on Bioanalytical Methods Validation for Macromolecules: Summary Report , 2001, Pharmaceutical Research.

[6]  A Yacobi,et al.  Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies , 1991, European Journal of Drug Metabolism and Pharmacokinetics.

[7]  D. J. Finney,et al.  The Form and Estimation of a Variance Function, with Particular Reference to Radioimmunoassay , 1977 .

[8]  P. Gottschalk,et al.  The five-parameter logistic: a characterization and comparison with the four-parameter logistic. , 2005, Analytical biochemistry.

[9]  D Rodbard,et al.  Statistical analysis of radioligand assay data. , 1975, Methods in enzymology.

[10]  Binodh DeSilva,et al.  Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules , 2003, Pharmaceutical Research.

[11]  D. Rodbard,et al.  [1] Statistical analysis of radioligand assay data , 1975 .

[12]  H. T. Karnes,et al.  Calibration and validation of linearity in chromatographic biopharmaceutical analysis. , 1991, Journal of pharmaceutical and biomedical analysis.

[13]  D. J. Finney Statistical Method in Biological Assay , 1966 .

[14]  Sidney Addelman,et al.  trans-Dimethanolbis(1,1,1-trifluoro-5,5-dimethylhexane-2,4-dionato)zinc(II) , 2008, Acta crystallographica. Section E, Structure reports online.

[15]  D. J. Finney,et al.  Guidelines for immunoassay data processing. , 1985, Clinical chemistry.

[16]  Thomas Layloff,et al.  Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies , 1992, Pharmaceutical Research.

[17]  D. Ruppert,et al.  Transformation and Weighting in Regression , 1988 .

[18]  Vinod P. Shah,et al.  Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays , 2007 .

[19]  Vinod P. Shah,et al.  Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays , 2007 .

[20]  M C Haven,et al.  Data-reduction methods for immunoradiometric assays of thyrotropin compared. , 1987, Clinical chemistry.

[21]  J. W. Findlay,et al.  Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. , 2000, Journal of pharmaceutical and biomedical analysis.

[22]  Robert Singer,et al.  Bioassay Glossary , 2006 .

[23]  Vinod P. Shah,et al.  Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays , 2007, The AAPS Journal.

[24]  Vinod P. Shah,et al.  Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.